SANTOS DAVID A (EVP, Chief Commercial Officer) reported 1 transaction at RIGEL PHARMACEUTICALS INC
Review the transaction codes below to understand the nature of each event.
Filed: 2/12/2026ACC: 0000905148-26-000679
Officer· EVP, Chief Commercial Officer
Since Aug 2020
-3.55K
Net shares
Net seller
$122.8K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
3.55K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−3.55K
Price / share
$34.62
Trade value
$122.76K
% of position
7.5%
2/10/2026
46.99K→43.44K
Total
Net shares
−3.55K
Net value
-$122.76K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/10/2026 | F · Tax Withholding | −3.55K | $34.62 | $122.76K | 7.5% | 46.99K | 43.44K |
| Total | −3.55K | -$122.76K | ||||||
Derivative Transactions0
No derivative transactions reported